DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cabergoline (Cabergoline) - Death - Suspected Cause - Side Effect Reports

 
 



Index of reports > Death (6)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cabergoline death. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Cabergoline side effects in

Reported by a physician from United States on 2012-04-06

Patient:

Reactions: Caesarean Section, Maternal Drugs Affecting Foetus, Premature Separation of Placenta

Adverse event resulted in: death

Drug(s) suspected as cause:
Cabergoline



Possible Cabergoline side effects in 77 year old male

Reported by a physician from Japan on 2011-12-02

Patient: 77 year old male, weighing 47.0 kg (103.4 pounds)

Reactions: Pleural Fibrosis, Pulmonary Fibrosis

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cabergoline

Other drugs received by patient: Estazolam; Opalmon; Almarl; Menest; Etodolac



Possible Cabergoline side effects in 50 year old male

Reported by a individual with unspecified qualification from United States on 2011-12-02

Patient: 50 year old male

Reactions: Dysphagia, Post Procedural Complication, Hyperglycaemia, Pituitary Tumour, Small Cell Carcinoma, Cushing's Syndrome, Metastases To Spine, Secondary Hypogonadism, Cranial Nerve Paralysis, Hypertension, Neuroendocrine Tumour, Metastases To Bone

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Octreotide Acetate
    Dosage: 900 mcg (300 mcg,3 in 1 d),subcutaneous
    Indication: Blood Corticotrophin Increased

Metyrapone (Metyrapone)
    Dosage: 500 mg (250 mg,2 in 1 d),oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Cabergoline
    Dosage: 0.4286 mg (1.5 mg,2 in 1 wk)
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Cisplatin; Etoposide; Capecitabnie (Capecitabine); Temozolamide (Temozolamide); Rosiglitazone



Possible Cabergoline side effects in 77 year old male

Reported by a physician from Japan on 2011-11-18

Patient: 77 year old male

Reactions: Pulmonary Fibrosis, Pleural Fibrosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cabergoline



Possible Cabergoline side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-10

Patient: 50 year old male

Reactions: Neoplasm Progression, Skin Hyperpigmentation, Headache, Death, Fatigue, Aspiration, Eye Movement Disorder, Back Pain, Pupillary Reflex Impaired, Dysphagia, Hyperglycaemia, Muscular Weakness, Hypoaesthesia, Hemianopia, Blood Corticotrophin Increased, Areflexia, Cortisol Free Urine Increased, Memory Impairment, Anosmia, Metastases To Bone

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Octreotide Acetate
    Dosage: 300 ug, tid

Cabergoline
    Dosage: 0.5 mg, twice a week
    Administration route: Oral

Metyrapone
    Dosage: 250 mg, bid
    Administration route: Oral

Octreotide Acetate
    Dosage: 300 ug, tid
    Indication: Blood Corticotrophin Increased

Other drugs received by patient: Rosiglitazone; Capecitabine; Cisplatin; Temozolomide; Etoposide



Possible Cabergoline side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-10

Patient: 50 year old male

Reactions: Neoplasm Progression, Skin Hyperpigmentation, Headache, Death, Fatigue, Aspiration, Eye Movement Disorder, Pupillary Reflex Impaired, Back Pain, Dysphagia, Hyperglycaemia, Muscular Weakness, Hypoaesthesia, Hemianopia, Blood Corticotrophin Increased, Cortisol Free Urine Increased, Areflexia, Memory Impairment, Anosmia, Metastases To Bone

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Octreotide Acetate
    Dosage: 300 ug, tid

Octreotide Acetate
    Dosage: 300 ug, tid
    Indication: Blood Corticotrophin Increased

Metyrapone
    Dosage: 250 mg, bid
    Administration route: Oral

Cabergoline
    Dosage: 0.5 mg, twice a week
    Administration route: Oral

Other drugs received by patient: Capecitabine; Temozolomide; Cisplatin; Etoposide; Rosiglitazone

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017